Liang Su

20 papers and 843 indexed citations i.

Liang Su has authored 20 papers that have received a total of 843 indexed citations. This includes 10 papers in Molecular Biology, 5 papers in Infectious Diseases and 4 papers in Oncology. The topics of these papers are COVID-19 Clinical Research Studies (3 papers), Peptidase Inhibition and Analysis (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). Liang Su is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Peptidase Inhibition and Analysis (2 papers) and Nanoparticle-Based Drug Delivery (2 papers) and collaborates with scholars based in China and United States. Liang Su's co-authors include Dong Liang, Huan Xie, Cheng‐Bao Zhu, Jing Ma and Jianjun Paul Tian and has published in prestigious journals such as ACS Nano, PLoS ONE and Frontiers in Immunology.